A Split-Face Comparison of Novel Microneedle Patch versus Botulinum Toxin-A and Microneedle Patch for Improvement in Undereye Skin Texture
- Conditions
- Healthy populationmicroneedle patch, transdermal drug delivery, wrinkle, botulinum toxin
- Registration Number
- TCTR20231002007
- Lead Sponsor
- Thammasat University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 23
Patients' consent was also obtained prior to the use of the images for medical purposes. Based on the Scientific Assessment Scale of Skin Quality (SASSQ) and Merz infraorbital hollow rating scale, all participants presented moderate to severe skin texture
there was a history of filler use within one year of study enrollment; the use of botulinum toxin injection in the previous six months; use of laser therapy in the previous six months of laser therapy; a history of light or radiofrequency use to the face; or the use of chemical peel within three months of study recruitment. Volunteers with existing infectious skin disease or eczematous dermatitis, those taking immunosuppressive therapy, women with hypersensitivity or allergy to cosmetics, those using a topical anti-wrinkle regimen for at least three months prior to recruitment, and pregnant or lactating women were also excluded from participating in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SASSQ skin quality rating scale 16 weeks photo
- Secondary Outcome Measures
Name Time Method Merz infraorbital hollow scale 16 weeks photo